Two-Year test for new migraine pill aims to cut headache days in half
NCT ID NCT06409832
Summary
This study aims to see how well and how safely the medication rimegepant works to prevent migraines in everyday life. It will follow 100 people with frequent migraines for two years as they take the medication every other day. Researchers will track how many migraine days they have, their quality of life, and any side effects to understand the drug's long-term benefits and safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIGRAINE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
IRCCS National Neurological Institute "C. Mondino" Foundation
RECRUITINGPavia, 27100, Italy
Contact Email: •••••@•••••
-
SOD Centro Cefalee e Farmacologia Clinica, AOU Careggi
RECRUITINGFlorence, 50134, Italy
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.